Chronic Lymphocytic Leukemia Activities

PROGRAM CHAIR

Sandra E. Kurtin, RN, MS, AOCN®, ANP-C
Clinical Assistant Professor of Medicine
Adjunct Clinical Assistant Professor of Nursing
The University of Arizona Cancer Center • Tucson, Arizona


These educational activities are supported by an educational grant from Pharmacyclics LLC, an AbbVie Company, and Janssen Biotech, Inc.

Management of Newly Diagnosed Chronic Lymphocytic Leukemia Patients

Chronic lymphocytic leukemia (CLL), a B-cell lymphoproliferative disorder, is one of the most common forms of leukemia. It can present as indolent disease or aggressive, rapidly progressive disease. This activity will provide an overview of the epidemiology, signs and symptoms, diagnostic work-up, immunohistochemistry, flow cytometry, and clinical staging of CLL. Understanding the complexity and characteristics of CLL will equip advanced practitioners with the knowledge necessary for the clinical management of newly diagnosed CLL patients.

Posted: 9/27/2016                     Expires: 5/30/2017

Credits/Contact Hours: 0.75

Access the Activity for Credit*
   
Participate Without Claiming Credit

* This link will take you to the
Meniscus Educational Institute website.


Relapsed or Refractory Chronic Lymphocytic Leukemia and the Management of Chronic Lymphocytic Leukemia Patients Treated With Immunotherapy

This activity will provide advanced practitioners with up-to-date information on relapsed or refractory CLL to assist in clinical decision making, including the pathobiology at the core of Richter’s transformation. This session will also provide important information on emerging immunotherapies, which have added to the armamentarium in the treatment of CLL.

Posted: 9/27/2016                     Expires: 5/30/2017

Credits/Contact Hours: 0.75

Access the Activity for Credit*
   
Participate Without Claiming Credit

* This link will take you to the
Meniscus Educational Institute website.


Supportive Care in Chronic Lymphocytic Leukemia

CLL patients are at risk for developing complications such as autoimmunity, infections, and tumor lysis syndrome. Advanced practitioners need to understand these complications, including monitoring, preventive measures, and management strategies. This activity will provide the advanced practitioner with key takeaways needed to face the challenges in caring for CLL-related complications and ensure the best patient outcomes.

Posted: 9/27/2016                     Expires: 5/30/2017

Credits/Contact Hours: 0.50

Access the Activity for Credit*
   
Participate Without Claiming Credit

* This link will take you to the
Meniscus Educational Institute website.


Copyright © 2016 Harborside Press, LLC All rights reserved.                Home | Current Issue | Previous Issue | Submissions | About JADPRO | Advertising | Privacy Policy | Contact
Copyright Notice/Disclaimer
Bot trap - Don't go here
click me